San Francisco VA Antibiograms
CUMULATIVE ANTIMICROBIAL SUSCEPTIBILITY REPORT
January 1, 2024 – December 31, 2024
Please note the following comments:
- All data is reported as percent fully susceptible
- First isolate per patient per organism is counted in the antibiogram
- 30 organisms are required to report susceptibilities on an antibiogram per CLSI guidelines. Some organisms were included in despite less than 30 organisms isolated
- When treating UTIs caused by E. Coli, Klebsiella spp., and Proteus spp., cefazolin can be used to predict results for the following oral agents: cephalexin (Keflex) and cefpodoxime (Vantin)
- Gentamicin susceptibilities for Enterococcus spp. are for gram-positive synergy
- Non-urine coagulase-negative Staphylococcus includes: S. auricularis, S. capitis, S. haemolyticus, S. hominis, S. lugdunensis, S. simulans, S. ureilyticus, S. warneri
- Urine coagulase-negative Staphylococcus includes: S. epidermidis, S. haemolyticus, S. lugdunensis, and S. warneri
- Key: ESBL: Extended-spectrum beta-lactamase; CR: Carbapenem resistant; VRE: Vancomycin resistant enterococci; MR: Methicillin resistant; NA: Not available; R: Intrinsically resistant
